Surmodics (Surmodics) EV-to-EBIT : 27.74 (As of Apr. 25, 2024)

Surmodics EV-to-EBIT Chart

Surmodics Annual Data
	Trend	Sep14	Sep15	Sep16	Sep17	Sep18	Sep19	Sep20	Sep21	Sep22	Sep23
EV-to-EBIT		Get a 7-Day Free Trial					72.94	-359.32	112.32	-19.29	73.98

Surmodics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															-19.06	-12.32	340.77	73.98	38.72

Competitive Comparison of Surmodics's EV-to-EBIT

For the Medical Devices subindustry, Surmodics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Surmodics's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surmodics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Surmodics's EV-to-EBIT falls into.

Surmodics EV-to-EBIT Calculation

Surmodics's EV-to-EBIT for today is calculated as:

Surmodics's current Enterprise Value is $369.8 Mil.
Surmodics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surmodics  (NAS:SRDX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Surmodics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Surmodics's Enterprise Value for the quarter that ended in Dec. 2023 was $516.1 Mil.
Surmodics's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surmodics EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Surmodics's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Surmodics (Surmodics) Business Description